Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Contact information

Email
david.priestman@pharm.ox.ac.uk

Telephone
+44 (0)1865 281116

David Priestman

Senior Research Fellow

Recent publications

Compartmentalization proteomics revealed endolysosomal protein network changes in a goat model of atrial fibrillation.

Ayagama T. et al, (2024), iScience, 27

A Mouse Systems Genetics Approach Reveals Common and Uncommon Genetic Modifiers of Hepatic Lysosomal Enzyme Activities and Glycosphingolipids.

Durán A. et al, (2023), Int J Mol Sci, 24

Glucosamine amends CNS pathology in mucopolysaccharidosis IIIC mouse expressing misfolded HGSNAT.

Pan X. et al, (2022), J Exp Med, 219

Glycosphingolipid metabolism and its role in ageing and Parkinson's disease.

Wallom K-L. et al, (2022), Glycoconj J, 39, 39 - 53

An iPSC model of Hereditary Sensory Neuropathy type-1 reveals Serine responsive deficits in neuronal ganglioside composition and axoglial interactions

CLARK A., (2021), Cell Reports Medicine

More publications